From: Feasibility of up-regulating CD4+CD25+ Tregs by IFN-γ in myasthenia gravis patients
No. | Sex | Age | Osserman’s classification | Thymic history |
---|---|---|---|---|
1 | F | 23 | IIA | Thymic hyperplasia |
2 | F | 23 | I | _ |
3 | M | 27 | I | _ |
4 | F | 28 | IIA | Thymoma |
5 | M | 32 | I | _ |
6 | M | 33 | I | _ |
7 | F | 35 | IIA | _ |
8 | M | 45 | IIA | Thymoma |
9 | M | 48 | I | Thymic hyperplasia |
10 | M | 48 | IIA | Thymoma |
11 | F | 50 | IIA | _ |
12 | F | 55 | IIA | Thymic hyperplasia |
13 | M | 58 | IIA | _ |
14 | M | 59 | IIA | _ |
15 | M | 62 | I | _ |
16 | F | 63 | IIA | Thymic hyperplasia |
17 | M | 67 | I | _ |
18 | M | 67 | IIA | _ |
19 | F | 69 | IIB | Thymoma |
20 | F | 69 | IIA | Thymoma |
21 | M | 73 | IV | _ |
22 | F | 76 | IIB | Thymic hyperplasia |
23 | F | 79 | IIB | _ |